Literature DB >> 12782149

Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1.

Zufan Araya1, Fardin Hosseinpour, Karl Bodin, Kjell Wikvall.   

Abstract

The metabolism of 25-hydroxyvitamin D(3) was studied with a crude mitochondrial cytochrome P450 extract from pig kidney and with recombinant human CYP27A1 (mitochondrial vitamin D(3) 25-hydroxylase) and porcine CYP2D25 (microsomal vitamin D(3) 25-hydroxylase). The kidney mitochondrial cytochrome P450 catalyzed the formation of 1alpha,25-dihydroxyvitamin D(3), 24,25-dihydroxyvitamin D(3) and 25,27-dihydroxyvitamin D(3). An additional metabolite that was separated from the other hydroxylated products on HPLC was also formed. The formation of this 25-hydroxyvitamin D(3) metabolite was dependent on NADPH and the mitochondrial electron transferring protein components. A monoclonal antibody directed against purified pig liver CYP27A1 immunoprecipitated the 1alpha- and 27-hydroxylase activities towards 25-hydroxyvitamin D(3) as well as the formation of the unknown metabolite. These results together with substrate inhibition experiments indicate that CYP27A1 is responsible for the formation of the unknown 25-hydroxyvitamin D(3) metabolite in kidney. Recombinant human CYP27A1 was found to convert 25-hydroxyvitamin D(3) into 1alpha,25-dihydroxyvitamin D(3), 25,27-dihydroxyvitamin D(3) and a major metabolite with the same retention time on HPLC as that formed by kidney mitochondrial cytochrome P450. Gas chromatography-mass spectrometry (GC-MS) analysis of the unknown enzymatic product revealed it to be a triol different from other known hydroxylated 25-hydroxyvitamin D(3) metabolites such as 1alpha,25-, 23,25-, 24,25-, 25,26- or 25,27-dihydroxyvitamin D(3). The product had the mass spectrometic properties expected for 4beta,25-dihydroxyvitamin D(3). Recombinant porcine CYP2D25 converted 25-hydroxyvitamin D(3) into 1alpha,25-dihydroxyvitamin D(3) and 25,26-dihydroxyvitamin D(3). It can be concluded that both CYP27A1 and CYP2D25 are able to carry out multiple hydroxylations of 25-hydroxyvitamin D(3).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782149     DOI: 10.1016/s1388-1981(03)00062-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

2.  An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

Authors:  Zhican Wang; Yvonne S Lin; Xi Emily Zheng; Tauri Senn; Takanori Hashizume; Michele Scian; Leslie J Dickmann; Sidney D Nelson; Thomas A Baillie; Mary F Hebert; David Blough; Connie L Davis; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2011-12-28       Impact factor: 4.436

Review 3.  From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D.

Authors:  John T Pinto; Arthur J L Cooper
Journal:  Adv Nutr       Date:  2014-03-01       Impact factor: 8.701

4.  Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.

Authors:  Zhican Wang; Tauri Senn; Tom Kalhorn; Xi Emily Zheng; Songmao Zheng; Connie L Davis; Mary F Hebert; Yvonne S Lin; Kenneth E Thummel
Journal:  Anal Biochem       Date:  2011-07-13       Impact factor: 3.365

Review 5.  The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies.

Authors:  Massimiliano Berretta; Vincenzo Quagliariello; Alessia Bignucolo; Sergio Facchini; Nicola Maurea; Raffaele Di Francia; Francesco Fiorica; Saman Sharifi; Silvia Bressan; Sara N Richter; Valentina Camozzi; Luca Rinaldi; Carla Scaroni; Monica Montopoli
Journal:  Antioxidants (Basel)       Date:  2022-05-30

6.  Short-term dietary phosphate restriction up-regulates ileal fibroblast growth factor 15 gene expression in mice.

Authors:  Otoki Nakahashi; Hironori Yamamoto; Sarasa Tanaka; Mina Kozai; Yuichiro Takei; Masashi Masuda; Ichiro Kaneko; Yutaka Taketani; Masayuki Iwano; Ken-Ichi Miyamoto; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2014-03-01       Impact factor: 3.114

7.  TGR5 Activation Ameliorates Mitochondrial Homeostasis via Regulating the PKCδ/Drp1-HK2 Signaling in Diabetic Retinopathy.

Authors:  Meng-Yuan Zhang; Lingpeng Zhu; Xinhua Zheng; Tian-Hua Xie; Wenjuan Wang; Jian Zou; Yan Li; Hong-Ying Li; Jiping Cai; Shun Gu; Yong Yao; Ting-Ting Wei
Journal:  Front Cell Dev Biol       Date:  2022-01-14

Review 8.  Bioconversion of vitamin D3 to bioactive calcifediol and calcitriol as high-value compounds.

Authors:  Zheyi Wang; Yan Zeng; Hongmin Jia; Niping Yang; Mengshuang Liu; Mingyue Jiang; Yanning Zheng
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-10-13

9.  Using Machine Learning to Identify Adverse Drug Effects Posing Increased Risk to Women.

Authors:  Payal Chandak; Nicholas P Tatonetti
Journal:  Patterns (N Y)       Date:  2020-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.